Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-04-11, with 92 holding rows worth $811,255,000.

Accession
0001415889-18-000595
Filed
2018-04-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 92 entries on the cover page, a total value of $811,255,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $811,255,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HORIZON PHARMA PLCG4617B105SHS2,007,212$28,502,000thousands by filing date
CELGENE CORP151020104COM296,412$26,443,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM221,863$24,729,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM150,000$24,447,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock148,436$22,412,000thousands by filing date
ABIOMED INC003654100COM76,490$22,258,000thousands by filing date
Bristol-Myers Squibb Company110122108COM350,000$22,138,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM207,458$22,044,000thousands by filing date
EXELIXIS INC COM30161Q104Stock986,214$21,845,000thousands by filing date
AbbVie,Inc.00287Y109COM206,700$19,564,000thousands by filing date
CIGNA CORPORATION125509109COM110,400$18,518,000thousands by filing date
HUMANA INC COM444859102Stock68,000$18,280,000thousands by filing date
Gilead Sciences,Inc.375558103COM237,027$17,869,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock244,540$17,688,000thousands by filing date
UnitedHealth Group Inc91324P102COM81,000$17,334,000thousands by filing date
Eli Lilly and Company532457108COM222,859$17,243,000thousands by filing date
Medtronic PlcG5960L103COM211,283$16,949,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK792,730$16,687,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM204,849$16,607,000thousands by filing date
BECTON DICKINSON & CO075887109COM75,000$16,253,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM944,185$15,957,000thousands by filing date
CVS Health Corporation126650100COM253,868$15,793,000thousands by filing date
GLAUKOS CORP COM377322102Stock503,400$15,520,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM95,000$15,302,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM215,000$14,852,000thousands by filing date
Elevance Health, Inc.036752103COM61,000$13,402,000thousands by filing date
INCYTE CORP COM45337C102Stock158,963$13,246,000thousands by filing date
Abbott Laboratories002824100COM202,000$12,104,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock34,000$11,708,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock83,364$11,631,000thousands by filing date
BIOGEN INC COM09062X103Stock42,300$11,583,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock701,470$11,448,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW285,642$11,283,000thousands by filing date
ALLERGAN PLCG0177J108SHS60,000$10,097,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock83,967$10,000,000thousands by filing date
Boston Scientific Corporation101137107COM347,968$9,506,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS435,000$9,483,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM110,000$9,122,000thousands by filing date
XENCOR INC98401F105COMMON STOCK300,000$8,994,000thousands by filing date
CENCORA INC COM03073E105Stock104,261$8,988,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock270,248$8,826,000thousands by filing date
LOXO ONCOLOGY INC548862101COM75,000$8,653,000thousands by filing date
MYOKARDIA INC62857M105COM168,272$8,212,000thousands by filing date
FIBROGEN INC31572Q808COM169,547$7,833,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM95,000$7,769,000thousands by filing date
MACROGENICS INC556099109COM300,000$7,548,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock65,000$6,947,000thousands by filing date
SEATTLE GENETICS INC812578102COM130,000$6,804,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM203,181$6,258,000thousands by filing date
IMMUNOMEDICS INC452907108COM415,330$6,068,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM270,000$6,067,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,617,769$5,727,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM236,686$5,304,000thousands by filing date
ALKERMES PLCG01767105SHS90,800$5,263,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM209,644$5,010,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM75,000$4,910,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM255,793$4,860,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM67,600$4,501,000thousands by filing date
LIVANOVA PLCG5509L901SHS50,000$4,425,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM350,000$3,868,000thousands by filing date
ENDOLOGIX INC29266S106COM906,002$3,832,000thousands by filing date
MEDICINES CO584688105COM100,000$3,294,000thousands by filing date
EPIZYME INC29428V104COM181,291$3,218,000thousands by filing date
OMNICELL COM COM68213N109Stock58,445$2,537,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM667,800$2,478,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM40,000$2,170,000thousands by filing date
Viewra, Inc92672L107COM332,385$2,137,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM300,000$2,046,000thousands by filing date
ZOGENIX INC.98978L204Common Stock50,000$2,003,000thousands by filing date
CHIMERIX INC COM16934W106Stock342,000$1,778,000thousands by filing date
NEWLINK GENETICS CORP651511107COM181,047$1,313,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK302,157$1,236,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM450,100$1,224,000thousands by filing date
DERMIRA INC24983L104COM95,000$759,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock127,006$737,000thousands by filing date
HALLIBURTON CO COM406216101Stock14,659$688,000thousands by filing date
EXXON MOBIL CORP30231G102COM8,526$636,000thousands by filing date
JPMorgan Chase & Co46625H100COM5,391$593,000thousands by filing date
JANUS HENDERSON GROUP PLCG4474Y904ORD SHS17,859$591,000thousands by filing date
International Business Machines Corporation459200101COM3,773$579,000thousands by filing date
Microsoft Corp594918104COM5,465$499,000thousands by filing date
Chevron Corporation166764100COM4,148$473,000thousands by filing date
FORD MTR CO COM345370860Stock42,606$472,000thousands by filing date
Walt Disney Co254687106COM4,613$463,000thousands by filing date
ANHEUSER BUSCH INBEV SA NV SPONSORED ADR03524A108ADR4,209$463,000thousands by filing date
Qualcomm Incorporated747525103COM8,052$446,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock24,658$365,000thousands by filing date
SYMANTEC CORP871503108COM14,039$363,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM492,878$354,000thousands by filing date
Pfizer Inc.717081103COM8,754$311,000thousands by filing date
Wells Fargo & Company949746101COM5,858$307,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM39,115$208,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-18-000595this filing2018-04-11acceptance time not in the bulk data set